Navigation Links
Author Royalties From Autism Book Donated to Autism Research
Date:11/3/2008

PHILADELPHIA, Nov. 3 /PRNewswire-USNewswire/ -- Paul Offit, MD, announced today that all author royalties earned from the sale of his new book, "Autism's False Prophets: Bad Science, Risky Medicine, and the Search for a Cure," will be donated to the Center for Autism Research at Children's Hospital of Philadelphia.

(Photo: http://www.newscom.com/cgi-bin/prnh/20081103/DC43575)

"We are very pleased to partner with Dr. Offit, and to accept the royalties of his book for the work done here at the Center for Autism Research (CAR) at Children's Hospital of Philadelphia," said Dr. Bob Schultz, director of the Center for Autism Research at Children's Hospital. "CAR is dedicated to helping children with an autism spectrum disorder (ASD) and their families. CAR's mission is to identify the causes of ASD, and from that knowledge devise effective treatments. By donating profits from his book, Dr. Offit is helping to push science forward for the good of all."

Dr. Offit, who is chief of Infectious Disease and director of the Vaccine Education Center at Children's Hospital, recounts the history of autism research and argues that antivaccination forces have misled the public by claiming a false link between vaccines and autism, a challenging neurological condition whose true cause remains unknown.

Dr. Offit's book underscores the importance of dedicating scarce social resources toward supporting legitimate scientific research into autism, rather than being needlessly diverted into implausible and scientifically unsupported treatments.

Paul A. Offit, M.D. is the chief of Infectious Diseases and the director of the Vaccine Education Center at the Children's Hospital of Philadelphia as well as the Maurice R. Hilleman Professor of Vaccinology and professor of pediatrics at the University of Pennsylvania School of Medicine. He has received numerous awards, including the J. Edmund Bradley Prize for Excellence in Pediatrics from the University of Maryland School of Medicine, the Young Investigator Award in Vaccine Development from the Infectious Diseases Society of America, and a Research Career Development Award from the National Institutes of Health. An international expert on rotavirus-specific immune responses, Dr. Offit is the co-inventor of the rotavirus vaccine RotaTeq, for which he received the Jonas Salk Award from the Association for Professionals in Infection Control and Epidemiology, the Gold Medal from the Children's Hospital of Philadelphia, and the Stanley A. Plotkin Award in Vaccinology from the Pediatric Infectious Diseases Society.

Media Contact:

Rachel Salis-Silverman

The Children's Hospital of Philadelphia

267-426-6063

Salis@email.chop.edu


'/>"/>
SOURCE The Children's Hospital of Philadelphia
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Author royalties from autism book donated to autism research
2. Pennsylvania Patient Safety Authority Hires Director of Educational Programs
3. Triple-S Management Corporation Reports Third Quarter 2008 Results; Board Approves Share Repurchase Authorization of up to $40 Million
4. CPC Appoints Medical Product Service GmbH as Authorized European Representative for MedClose(TM) System
5. New Jersey Author Uncovers the Secret to Well-Being Is the Connection Between Health and Emotions
6. Tianyin Pharmaceutical Co., Inc. Authorizes $3.0 Million Stock Repurchase Program
7. New Author Mary Soliel Honored as Two-time National Best Books 2008 Award Finalist
8. Patient Safety Authority Supports International Infection Prevention Week
9. American Association for the Study of Liver Diseases Enters Into Agreement With Clinical Care Options as Its Authorized Online Conference Coverage Provider for the Liver Meeting(R) 2008
10. Exercise Can Help You Cope with Financial Stress and Heal Emotional Pain, Says Acclaimed Author and Psychotherapist
11. Mt. Sinai Services Toronto Becomes an Xceed Authorized Gene-Expression Service Provider Using Ziplex(R) System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2016)... ... ... where’s it’s easy to spot the neon lights of chains serving fast food, one of ... taste for real food. , On May 13, the Best Western Plus Kelowna ... focusing on dishes made by hand with wholesome, organic ingredients that are sourced locally whenever ...
(Date:5/27/2016)... ... May 27, 2016 , ... Two director-level employees of Horizon Blue Cross ... and Industry (TWIN) 2016 honorees. The award recognizes businesswomen who excel in their ... Boone, Director of the MLTSS (Managed Long-Term Services and Supports) Program at Horizon NJ ...
(Date:5/27/2016)... ... May 27, 2016 , ... With over 60 percent ... the demand for a sustainable product to aid in the rehabilitation process has steadily ... the recovery of individuals with hemiplegia due to stroke. , Ekso Bionics has now ...
(Date:5/27/2016)... New York, NY (PRWEB) , ... May 27, ... ... has partnered with Mediaplanet to help educate the many who are unaware of ... section dedicated to aphasia will run within the “Stroke Awareness” campaign. , The ...
(Date:5/27/2016)... ... 2016 , ... Aimed at nurses and employees in the health care world, ... in the nursing and health care industry. It also provides insight to the developing ... , As the nursing industry is coming out of one of the biggest ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... NASHVILLE, Tenn. , May 26, 2016 ... provider of software and analytics, network solutions ... healthcare, today announced it entered into a ... leading provider of outpatient software solutions and ... surgery centers, specialty hospitals and rehabilitation clinics ...
(Date:5/25/2016)... , May 25,2016 ... the near-infrared Cellvizio platform for urological and surgical ... OTCQX: MKEAY) inventor of Cellvizio®, the multidisciplinary confocal ... regulatory milestone in the US with the 12 ... and Drug Administration (FDA). This new FDA clearance ...
(Date:5/25/2016)... GERMANTOWN, Maryland , May 25, 2016 ... bedient dringenden Bedarf zur ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt ... und Entwicklungsvereinbarung mit Therawis Diagnostics GmbH zur Entwicklung ... zu sein. Ein erstes Projekt wird die Entwicklung ...
Breaking Medicine Technology: